NCCN Summit Highlights New Strategies to Improve Cancer Prevention and Screening

NCCN Summit Highlights New Strategies to Improve Cancer Prevention and Screening

Cancer prevention and early detection took centre stage at a major health policy summit in Washington, D.C., as experts discussed ways to make cancer screening more accessible, effective and equitable.

The National Comprehensive Cancer Network (NCCN) hosted a two-day Oncology Policy Summit on October 5 and 6, bringing together healthcare professionals, policymakers, patients, advocates, insurers and other experts. The discussions focused on reducing cancer risk, improving screening and addressing barriers that prevent people from receiving potentially life-saving care.

Why Cancer Prevention and Screening Matter

Experts at the summit stressed that many opportunities already exist to prevent cancer or detect it earlier. However, access to these opportunities remains uneven.


Chyke Doubeni, MD, MPH, NCCN's Chief Health Equity Officer at The Ohio State University Wexner Medical Center, highlighted the potential of established prevention and screening strategies to substantially reduce cancer deaths. He also warned that barriers to healthcare access can prevent people from benefiting from these strategies.

The discussion comes as healthcare systems increasingly explore new technologies, including blood-based testing and artificial intelligence, to improve cancer detection.

Improving Access to Cancer Screening

One of the major themes of the summit was accessibility. Even when effective screening tests are available, people may face financial, geographical, organisational or other barriers that make it difficult to complete the recommended process.

Experts discussed the importance of creating better systems that can identify people who need screening, contact them at the right time and ensure that follow-up care does not get lost.

Value-based healthcare models were also discussed as a potential way to encourage preventive care through personalised outreach and evidence-based approaches.

New Technologies Could Change Early Detection
Technology was another important focus of the summit.

The first day examined emerging approaches such as blood-based cancer tests and artificial intelligence-driven efficiencies. These technologies could potentially make certain aspects of cancer screening easier or more efficient.

However, experts emphasised that innovation alone is not enough. New screening technologies must be introduced in ways that allow people from different communities and backgrounds to benefit from them.

Without addressing existing gaps in healthcare delivery, new technologies could potentially increase rather than reduce disparities, according to summit discussions.

Focus on People at Higher Risk

The second day shifted towards individual screening needs, particularly for people with higher cancer risks.

Topics included hereditary cancer risk, genetic testing, follow-up diagnostics, out-of-pocket expenses and continuity of care.

This reflects an important point: cancer risk is not identical for everyone. Family history, genetics, lifestyle, age and other factors can influence the type and timing of screening that may be appropriate.

Experts also stressed that people want practical information about what they can do to reduce their personal cancer risk—not simply a risk score or percentage.

Free Resources for Patients

The summit also highlighted patient-friendly resources from the NCCN.

The organisation provides free NCCN Guidelines for Patients covering topics including breast cancer screening and diagnosis, colorectal cancer screening, genetic testing, lung cancer screening and prostate cancer screening. The materials are available in English and Spanish and are designed to help people understand screening and discuss healthcare decisions with their care teams.

The Bigger Picture

The NCCN summit demonstrates that improving cancer outcomes requires more than developing new treatments. Prevention, early detection, patient education and reliable access to healthcare are all important parts of reducing the cancer burden.

For individuals, following age- and risk-appropriate screening recommendations and discussing personal risk factors with a healthcare professional can be important steps. Screening recommendations can differ from person to person, so medical advice should be based on individual circumstances.

Conclusion

The 2026 NCCN Oncology Policy Summit placed cancer prevention, early detection and healthcare access at the centre of discussions among leading experts.

From tobacco cessation and vaccines to genetic testing, blood-based screening and artificial intelligence, the summit explored a broad range of strategies for reducing cancer risk and finding disease earlier. At the same time, experts emphasised that innovation must be accompanied by better access, affordability and continuity of care.

The overall message was clear: improving cancer prevention and screening is not only about developing better technology—it is also about ensuring that people can actually access and benefit from it.